These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33851590)

  • 1. LEVELS OF PROINFLAMMATORY CYTOKINES IL-17 AND IL-23 IN PATIENTS WITH ALZHEIMER'S DISEASE, MILD COGNITIVE IMPAIRMENT AND VASCULAR DEMENTIA.
    Dubenko OE; Chyniak OS; Potapov OO
    Wiad Lek; 2021; 74(1):68-71. PubMed ID: 33851590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of proinflammatory cytokines and vascular endothelial growth factor in patients with Alzheimer's disease and mild cognitive impairment].
    Malashenkova IK; Hailov NA; Krynskiy SA; Ogurtsov DP; Kazanova GV; Velichkovckiy BB; Selezneva ND; Fedorova YB; Ponomareva EV; Kolyhalov IV; Gavrilova SI; Didkovsky NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):39-43. PubMed ID: 27070471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    Lauriola M; D'Onofrio G; Ciccone F; Germano C; Cascavilla L; Paris F; Greco A
    J Alzheimers Dis; 2021; 82(1):235-248. PubMed ID: 34057086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.
    Vinceti M; Chiari A; Eichmüller M; Rothman KJ; Filippini T; Malagoli C; Weuve J; Tondelli M; Zamboni G; Nichelli PF; Michalke B
    Alzheimers Res Ther; 2017 Dec; 9(1):100. PubMed ID: 29258624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Asby D; Boche D; Allan S; Love S; Miners JS
    Brain; 2021 Jul; 144(6):1869-1883. PubMed ID: 33723589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment.
    Teksut TK; Irkec C; Altiparmak T; Fidan I
    J Clin Neurosci; 2022 Feb; 96():229-230. PubMed ID: 34933792
    [No Abstract]   [Full Text] [Related]  

  • 7. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
    J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
    Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
    Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
    Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.
    Forlenza OV; Diniz BS; Talib LL; Radanovic M; Yassuda MS; Ojopi EB; Gattaz WF
    Braz J Psychiatry; 2010 Sep; 32(3):216-22. PubMed ID: 20414590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia.
    Kim HJ; Lee JH; Cheong EN; Chung SE; Jo S; Shim WH; Hong YJ
    Curr Alzheimer Res; 2020; 17(10):893-903. PubMed ID: 33256581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease Burdens of Alzheimer's Disease, Vascular Dementia, and Mild Cognitive Impairment.
    Moon W; Han JW; Bae JB; Suh SW; Kim TH; Kwak KP; Kim BJ; Kim SG; Kim JL; Moon SW; Park JH; Ryu SH; Youn JC; Lee DY; Lee DW; Lee SB; Lee JJ; Jhoo JH; Kim KW
    J Am Med Dir Assoc; 2021 Oct; 22(10):2093-2099.e3. PubMed ID: 34237255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal Alzheimer's Disease Demonstrates Increased Errors at a Simple and Automated Anti-Saccade Task.
    Holden JG; Cosnard A; Laurens B; Asselineau J; Biotti D; Cubizolle S; Dupouy S; Formaglio M; Koric L; Seassau M; Tilikete C; Vighetto A; Tison F
    J Alzheimers Dis; 2018; 65(4):1209-1223. PubMed ID: 30149445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hippocampal volume measured using magnetic resonance imaging in Alzheimer's disease, vascular dementia, mild cognitive impairment and pseudodementia.
    Dolek N; Saylisoy S; Ozbabalik D; Adapinar B
    J Int Med Res; 2012; 40(2):717-25. PubMed ID: 22613435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.